浅草薬粧
Berbesolone-F Betamethasone Sodium Phosphate/Radiomycin Sulfate Combined Eye and Nasal Drops: 5ml x 10 tubes
Berbesolone-F Betamethasone Sodium Phosphate/Radiomycin Sulfate Combined Eye and Nasal Drops: 5ml x 10 tubes
無法載入取貨服務供應情況
Notice
◆This product requires refrigeration, but can only be shipped at room temperature. Please refrigerate it immediately upon arrival. Please be aware of this.
Product Features
The combination of synthetic corticosteroids (steroids) that suppress inflammation with antibiotics that have antibacterial activity can suppress inflammation in the eyes and nose and relieve symptoms.
It is commonly used to treat inflammatory eye diseases accompanied by bacterial infection by eye drops, to treat allergic rhinitis and progressive gangrenous rhinitis by nasal drops, and for postoperative treatment of the nose and throat.
Specification
5ml x 10 vials
Properties
liquid
Ingredients
In 1 mL: Betamethasone sodium phosphate 1 mg, radiomycin sulfate 3.5 mg
Additives: anhydrous sodium sulfite, methyl paraben, propyl paraben, anhydrous sodium monohydrogen phosphate, crystalline sodium dihydrogen phosphate, tensioning agent
Indications
●Inflammatory diseases accompanied by bacterial eye infections ●Eczema and dermatitis of the external ear, progressive gangrenous rhinitis ●Postoperative management in the field of otolaryngology
Dosage and administration
●Eye drops: Normally, 1 to 2 drops per time, 1 to several times a day.
The dosage can be adjusted according to the symptoms.
● Nasal drops, etc., usually, once or several times a day, use a sprayer or cotton swabs to apply an appropriate amount of nasal drops.
The dosage can be adjusted according to the symptoms.
Precautions
●The following patients should not use this medication.
• Patients with a history of allergy to any component of this medication (betamethasone sodium phosphate, radiomycin sulfate)
• Individuals allergic to the following ingredients: • Aminoglycoside antibiotics such as streptomycin, kanamycin, gentamicin, and flammycin, as well as bacitracin.
●The following patients should not use this medication in principle.
• Those with corneal epithelial detachment or corneal ulcers • Viral conjunctival and corneal diseases, tuberculous ophthalmic diseases, fungal ophthalmic diseases.
• Patients with tuberculosis or viral diseases in the nose
●The following patients need to pay close attention after using this medication. If any changes occur in your body after use, please consult a doctor.
·diabetes
Share
